Guangzhou Jiayin Biotech Ltd
Guangzhou Jiayin Biotech Ltd
Explore linked clinical trials.6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Preliminary Efficacy of EXG202 Gene Therapy for Neovascular AMD | Wet Age-related Macular Degeneration | Not yet recruiting | Phase 1 / Phase 2 | 2025-09-17 | NCT07178249 | |
| A Long-term Follow up Study of EXG102-031 in Participants With wAMD | Wet Age-related Macular Degeneration | Recruiting | Not stated | 2025-08-15 | NCT06859515 | |
| Clinical Trial to Assess the Safety and Efficacy of EXG001-307 in Patients With Spinal Muscular Atrophy | central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Enrolling by invitation | Early phase 1 | 2025-03-21 | NCT06888661 | |
| To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovascular) Age-related Macular Degeneration (wAMD) | Wet Age-related Macular Degeneration; Wet Age-related Macular Degeneration (wAMD) | Not yet recruiting | Early phase 1 | 2025-03-21 | NCT06888492 | |
| A Long-term Follow-up Study Evaluating Intravenous Injection of EXG001-307 in Patients With Type 1 SMA | central nervous system disorder, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, spinal cord disorder, spinal muscular atrophy | Enrolling by invitation | Not stated | 2025-03-05 | NCT06588803 | |
| The Safety and Efficacy of Intravenous EXG110 in Patients With Fabry Disease | Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, Cerebral Small Vessel Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fabry disease, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lysosomal Storage Diseases, Nervous System, Nutritional and Metabolic Diseases, X-linked disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hereditary disease, inborn errors of metabolism, lysosomal lipid storage disorder, lysosomal storage disease, metabolic disease, nervous system disorder, sphingolipidosis, vascular disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-02-11 | NCT06819514 |